RVTY Revvity Inc.

  1. Stocks
  2. Healthcare
  3. NYSE: RVTY

Price (delayed)

$102.31

Market cap

$11.41B

P/E Ratio

49.19

Dividend/share

$0.28

EPS

$2.08

Enterprise value

$13.9B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 53

PerkinElmer enables scientists, researchers, and clinicians to address their most critical challenges across science and healthcare. With a mission focused on innovating for a healthier world, the company delivers unique ...

Highlights
The company's revenue rose by 4.8% YoY
The quick ratio has shrunk by 54% YoY
The stock's price to earnings (P/E) is 33% more than its 5-year quarterly average of 36.6 and 12% more than its last 4 quarters average of 43.3
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.perkinelmer.com
Peers: QTRX PRPO MTD

Key stats

What are the main financial stats of RVTY

RVTY stock price

How has the Revvity stock price performed over time
Intraday
1.23%
1 week
1.08%
1 month
18.26%
1 year
10.73%
YTD
5.75%
QTD
16.78%

Financial performance

How have Revvity's revenue and profit performed over time
Revenue
$2.9B
Gross profit
$1.58B
Operating income
$360.29M
Net income
$239.68M
Gross margin
54.3%
Net margin
8.3%
RVTY's net margin is down by 19% year-on-year
Revvity's net income has decreased by 16% YoY
The company's operating margin fell by 8% YoY
The company's revenue rose by 4.8% YoY

Price vs fundamentals

How does RVTY's price correlate with its fundamentals

Growth

What is Revvity's growth rate over time

Valuation

What is Revvity stock price valuation
RVTY P/E details
P/E
49.19
P/B
1.59
P/S
3.94
EV/EBIT
38.53
EV/EBITDA
17.97
EV/Sales
4.79
The stock's price to earnings (P/E) is 33% more than its 5-year quarterly average of 36.6 and 12% more than its last 4 quarters average of 43.3
The EPS has contracted by 11% YoY
The price to book (P/B) is 25% lower than the 5-year quarterly average of 2.1 but 12% higher than the last 4 quarters average of 1.4
The equity is down by 6% year-on-year
The price to sales (P/S) is 19% lower than the 5-year quarterly average of 4.8 but 5% higher than the last 4 quarters average of 3.7
The company's revenue rose by 4.8% YoY

Efficiency

How efficient is Revvity business performance
The company's return on assets fell by 13% YoY
RVTY's return on equity is down by 11% year-on-year but it is up by 3.1% since the previous quarter
RVTY's return on invested capital is up by 11% year-on-year and by 3.8% since the previous quarter
The ROS has contracted by 6% YoY

Dividends

What is RVTY's dividend history
Dividend details
DPS
$0.28
Dividend yield
0.27%
Payout ratio
13.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Revvity financials performed over time
The total assets is 149% greater than the total liabilities
The quick ratio has shrunk by 54% YoY
The current ratio has plunged by 52% YoY but it has grown by 2.4% from the previous quarter
RVTY's debt is 53% smaller than its equity
RVTY's debt to equity is up by 7% year-on-year and by 2.2% since the previous quarter
The equity is down by 6% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.